Home / Recalls / Zydus Pharmaceuticals (USA) Inc / D-0600-2024

D-0600-2024 Class II Terminated

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Recall Details

Product Type
Drugs
Report Date
July 24, 2024
Initiation Date
June 27, 2024
Termination Date
September 4, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
432250 vials

Product Description

Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.

Reason for Recall

Presence of particulate matter: glass

Distribution Pattern

TN

Code Information

Lot #: L200253, L200281, L200301, Exp 07/31/2024

Other recalls by Zydus Pharmaceuticals (USA) Inc

  • D-0400-2026 Class II — Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured (March 9, 2026)
  • D-0295-2026 Class II — Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: S (December 30, 2025)
  • D-0247-2026 Class III — traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufacture (December 19, 2025)
  • D-0159-2026 Class II — Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Man (October 23, 2025)
  • D-0153-2026 Class II — clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottle (October 22, 2025)
  • D-0152-2026 Class II — clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottle (October 22, 2025)
  • D-0154-2026 Class II — clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottle (October 22, 2025)
  • D-0002-2026 Class II — Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus L (September 24, 2025)
  • D-0001-2026 Class II — Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus (September 24, 2025)
  • D-0657-2025 Class II — Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesc (September 4, 2025)